Theriva Biologics Files 8-K

Ticker: TOVX · Form: 8-K · Filed: Oct 8, 2025 · CIK: 894158

Theriva Biologics, Inc. 8-K Filing Summary
FieldDetail
CompanyTheriva Biologics, Inc. (TOVX)
Form Type8-K
Filed DateOct 8, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, company-update

TL;DR

Theriva Biologics filed an 8-K on Oct 8, 2025, mostly for routine filings.

AI Summary

On October 8, 2025, Theriva Biologics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company was formerly known as Synthetic Biologics, Inc. and is incorporated in Nevada.

Why It Matters

This 8-K filing indicates Theriva Biologics is submitting required documentation to the SEC, potentially related to ongoing operations or financial reporting, though specific material events are not detailed in this excerpt.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing cover page and does not contain information about significant risks or material events.

Key Numbers

  • 001-12584 — Commission File Number (SEC filing identifier for Theriva Biologics)
  • 13-3808303 — IRS Employer Identification No. (Tax identification for Theriva Biologics)

Key Players & Entities

  • Theriva Biologics, Inc. (company) — Registrant
  • Synthetic Biologics, Inc. (company) — Former company name
  • October 8, 2025 (date) — Date of report
  • Nevada (jurisdiction) — State of incorporation

FAQ

What is the primary purpose of this 8-K filing by Theriva Biologics?

The filing is primarily for 'Other Events' and 'Financial Statements and Exhibits', indicating routine or administrative submissions rather than a specific material event.

When was this 8-K report filed?

The report was filed on October 8, 2025.

What was Theriva Biologics formerly known as?

Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc.

In which state is Theriva Biologics, Inc. incorporated?

Theriva Biologics, Inc. is incorporated in Nevada.

What are the business and mailing addresses listed for Theriva Biologics?

The business and mailing addresses are both listed as 9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850.

Filing Stats: 722 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2025-10-08 08:00:40

Key Financial Figures

  • $0.001 — ch registered Common stock, par value $0.001 per share TOVX NYSE American Indica

Filing Documents

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Preclinical Data presented at the 32 nd Annual Congress of the European Society of Gene & Cell Therapy 104 Cover Page Interactive Data File (embedded within the XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 8, 2025 THERIVA BIOLOGICS, INC. By: /s/ Steven A. Shallcross Name: Steven A. Shallcross Title: Chief Executive Officer and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.